ZETAFUSE
Live / Registered — Registered (as of 07 Mar 2023)
What this means for you
Registered since 07 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88425046
- Registration number
- 6996928
- Mark type
- Stylized text
- Filed
- 10 May 2019
- Published for opposition
- 10 Sept 2019
- Registered
- 07 Mar 2023
- Attorney of record
- Katherine P. Califa
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of bone diseases
- Class 010 — Medical apparatus: Bone setting machines and instruments; Medical apparatus and instruments for treating osteoarthritis, osteoporosis, osteotraumatic injuries, degenerative bone diseases and joint diseases; Medical apparatus and instruments for treating osteotraumatic injuries, degenerative bone diseases and joint diseases
Owner
- Zetagen Therapeutics, Inc., Syracuse, NY, US
- Zetagen Therapeutics, Inc., Syracuse, NY, US
- Zetagen Therapeutics, Inc., Syracuse, NY, US
Prosecution history
- 07 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 02 Feb 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Feb 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Jan 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Jan 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Jan 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Oct 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Oct 2022 — NON-FINAL ACTION E-MAILED
- 06 Oct 2022 — SU - NON-FINAL ACTION - WRITTEN
- 05 Oct 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Sept 2022 — USE AMENDMENT FILED
- 30 Sept 2022 — TEAS STATEMENT OF USE RECEIVED
- 04 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 May 2022 — SOU EXTENSION 5 GRANTED